Anti-HPV-E7 seropositivity and risk of esophageal squamous cell carcinoma in a high-risk population in China

Carcinogenesis

Volumn 35, Issue 4, 2014, Pages 816-821

  He, Zhonghu ^a   Xu, Zhongyao ^a   Hang, Dong ^a   Guo, Fangcen ^a   Abliz, Amir ^a   Weiss, Noel S ^b   Xi, Longfu ^b,c   Liu, Fangfang ^a   Ning, Tao ^a   Pan, Yaqi ^a   Guo, Chuanhai ^a   Liang, Yongmei ^a   Lu, Changdong ^d   Zhang, Lixin ^d   Cai, Hong ^a   Ke, Yang ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d Anyang Cancer Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; HUMAN PAPILLOMAVIRUS TYPE 16 E7 ANTIBODY; HUMAN PAPILLOMAVIRUS TYPE 18 E7 ANTIBODY; HUMAN PAPILLOMAVIRUS TYPE 57 E7 ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ANTIGEN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; CANCER RISK; CHINA; CONTROLLED STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROLOGY; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; CHINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84898636089     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt483     Document Type: Article

References (32)

1. Jemal, A. et al. (2011) Global cancer statistics. CA. Cancer J. Clin., 61, 69-90.
2. Gholipour, C. et al. (2008) A histopathological study of esophageal cancer on the western side of the Caspian littoral from 1994 to 2003. Dis. Esophagus, 21, 322-327.
3. Tran, G.D. et al. (2005) Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int. J. Cancer, 113, 456-463.
4. Zur Hausen, H. (1994) Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr. Top. Microbiol. Immunol., 186, 131-156.
5. Kreimer, A.R. et al. (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol. Biomarkers Prev., 14, 467-475.
6. Zur Hausen, H. (2009) Papillomaviruses in the causation of human cancers - a brief historical account. Virology, 384, 260-265.
7. D'Souza, G. et al. (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med., 356, 1944-1956.
8. Syrjänen, K. et al. (1982) Squamous cell papilloma of the esophagus: a tumour probably caused by human papilloma virus (HPV). Diagn. Histopathol., 5, 291-296.
9. Syrjänen, K.J. (1982) Histological changes identical to those of condylomatous lesions found in esophageal squamous cell carcinomas. Arch. Geschwulstforsch., 52, 283-292.
10. Koshiol, J. et al. (2010) No role for human papillomavirus in esophageal squamous cell carcinoma in China. Int. J. Cancer, 127, 93-100.
11. Syrjänen, K.J. (2002) HPV infections and oesophageal cancer. J. Clin. Pathol., 55, 721-728.
12. Guo, F. et al. (2012) Human papillomavirus infection and esophageal squamous cell carcinoma: a case-control study. Cancer Epidemiol. Biomarkers Prev., 21, 780-785.
13. Dillner, J. et al. (1995) Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma. BMJ, 311, 1346.
14. Bjørge, T. et al. (1997) Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ, 315, 646-649.
15. Lagergren, J. et al. (1999) Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden. J. Natl. Cancer Inst., 91, 156-162.
16. Van Doornum, G.J. et al. (2003) Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites. Br. J. Cancer, 88, 1095-1100.
17. Han, C. et al. (1996) Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi Province, China. J. Natl. Cancer Inst., 88, 1467-1471.
18. Sitas, F. et al. (2007) The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population. Infect. Agent. Cancer, 2, 6.
19. Kamangar, F. et al. (2006) Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in China. Int. J. Cancer, 119, 579-584.
20. Sitas, F. et al.; InterSCOPE Collaboration. (2012) InterSCOPE study: associations between esophageal squamous cell carcinoma and human papillomavirus serological markers. J. Natl. Cancer Inst., 104, 147-158.
21. Bjørge, T. et al. (1997) A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res., 57, 3989-3992.
22. Smith, E.M. et al. (2007) Human papillomavirus seropositivity and risks of head and neck cancer. Int. J. Cancer, 120, 825-832.
23. Schiffman, M. et al. (2007) Human papillomavirus and cervical cancer. Lancet, 370, 890-907.
24. Zur Hausen, H. et al. (1981) Papillomavirus infections and human genital cancer. Gynecol. Oncol., 12(2 Pt 2), S124-S128.
25. Wang, X. et al. (2010) Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptive study. BMC Cancer, 10, 19.
26. He, Z. et al. (2010) Evaluation of quality control procedures in an oesophageal cancer cohort study in Anyang, China. J. Hosp. Infect., 76, 336-339.
27. He, Z. et al. (2010) Prevalence and risk factors for esophageal squamous cell cancer and precursor lesions in Anyang, China: a population-based endoscopic survey. Br. J. Cancer, 103, 1085-1088.
28. Sehr, P. et al. (2001) A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J. Immunol. Methods, 253, 153-162.
29. Sehr, P. et al. (2002) HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. J. Virol. Methods, 106, 61-70.
30. Kirnbauer, R. et al. (1994) A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J. Natl. Cancer Inst., 86, 494-499.
31. Wideroff, L. et al. (1995) Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J. Infect. Dis., 172, 1425-1430.
32. Waterboer, T. et al. (2005) Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin. Chem., 51, 1845-1853.